"ovarian tumor" trang 15 - tải miễn phí từ tailieuXANH
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer

Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
18    221    1
KAZN as a diagnostic marker in ovarian cancer: A comprehensive analysis based on microarray, mRNA-sequencing, and methylation data

KAZN as a diagnostic marker in ovarian cancer: A comprehensive analysis based on microarray, mRNA-sequencing, and methylation data
12    164    1
Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin

Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
15    191    1
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
15    132    1
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis
7    19    1
Nomograms to predict the prognosis in malignant ovarian germ cell tumors: A large cohort study

Nomograms to predict the prognosis in malignant ovarian germ cell tumors: A large cohort study
11    10    1
NAP1L1 promotes tumor proliferation through HDGF/C-JUN signalling in ovarian cancer

NAP1L1 promotes tumor proliferation through HDGF/C-JUN signalling in ovarian cancer
10    8    1
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer
10    18    1
Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: A network meta-analysis

Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: A network meta-analysis
10    24    1
Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study

Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study
15    18    1
Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)

Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)
13    20    1
Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer

Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
9    16    1
Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): Study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): Study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial
12    14    1
The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma

The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
7    16    1
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer

Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer
19    22    1
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy

High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy
12    17    1
Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis

Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis
12    13    1
Ebook Ultrasound assessment in gynecologic oncology: Part 1

Ebook Ultrasound assessment in gynecologic oncology: Part 1
80    60    1
The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019

The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
41    16    1
Ovarian cancer: the recognition and initial management of ovarian cancer

Ovarian cancer: the recognition and initial management of ovarian cancer

1    65    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.